(3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
R-CMH is presented in the Swati Industries portfolio as a pharmaceutical intermediate. Its identity, grade, impurity profile and suitability for a specific downstream synthesis must be confirmed against the approved specification and batch COA.
Route scouting and reaction selectivity; impurity formation and purge studies; crystallization and isolation screening; residual solvent strategy; scale-up robustness and stability-indicating method development.
Identity by FTIR/NMR or LC-MS; assay and related substances by HPLC; residual solvents by GC; water content; appearance and batch-specific tests.
(3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
Open PubChem reference ↗Technical overview only; not a validated manufacturing process or a claim of company capability. Confirm chemical form, CAS No., grade and specifications from the approved specification and batch COA.